Chinook Therapeutics
-$0.16 (-1.06%) Today
$0.00 (0.00%) As of 8:01 AM UTC after-hours
Why Robinhood?
You can buy or sell KDNY and other stocks, options, and ETFs commission-free!
About KDNY
Chinook Therapeutics, Inc. Common Stock, also called Chinook Therapeutics, is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases.
CEO
Eric L. Dobmeier
Employees
105
Headquarters
Seattle, Washington
Founded
2000
KDNY Key Statistics
Market Cap
661.74M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
267.85K
High Today
$16.26
Low Today
$14.09
Open Price
$15.38
Volume
148.54K
52 Week High
$21.68
52 Week Low
$10.50
Analyst Ratings
100%
of 8 ratings
Buy
100%
Hold
0%
Sell
0%
KDNY Earnings
-$1.24
-$0.83
-$0.41
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.68 per share
Actual
-$0.88 per share